Thomas Dörner
Impact in
- Rheumatology top 0.01%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Immunology top 0.1%
- T-cell and B-cell Immunology
Papers in
- Rheumatology 235
- Systemic Lupus Erythematosus Research 172
- Rheumatoid Arthritis Research and Therapies 66
- Immunology 97
- T-cell and B-cell Immunology 80
- Biosimilars and Bioanalytical Methods 12
- Co-authors
- Peter E. Lipsky (57 shared papers)Gerd Rüdiger Burmester (63 shared papers)Andreas Radbruch (35 shared papers)Eva Vanessa Schrezenmeier (27 shared papers)Falk Hiepe (42 shared papers)Annett M. Jacobi (21 shared papers)Eugen Feist (26 shared papers)Richard Alan Furie (6 shared papers)
- Journals
- Annals of the Rheumatic Diseases (66 papers)Arthritis Research & Therapy (23 papers)Current Opinion in Rheumatology (13 papers)Nature Reviews Rheumatology (13 papers)Frontiers in Immunology (13 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Thomas Dörner
418 papers receiving 33.4k citations
Thomas Dörner's Hit Papers
Peers
Comparison fields: 5 of 165
- Rheumatology 14.8k
- Immunology 6.7k
- Physiology 3.5k
- Pathology and Forensic Medicine 1.7k
- Infectious Diseases 1.7k
Countries citing papers authored by Thomas Dörner
This map shows the geographic impact of Thomas Dörner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Dörner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Dörner more than expected).
Fields of papers citing papers by Thomas Dörner
This network shows the impact of papers produced by Thomas Dörner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Dörner. The network helps show where Thomas Dörner may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Dörner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 436 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus Hit paper breakdown → | 2019 | 1722 |
| 2 | Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology Hit paper breakdown → | 2020 | 1120 |
| 3 | 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus Hit paper breakdown → | 2019 | 1115 |
| 4 | IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases Hit paper breakdown → | 2014 | 877 |
| 5 | EULAR recommendations for the management of antiphospholipid syndrome in adults Hit paper breakdown → | 2019 | 852 |
| 6 | Competence and competition: the challenge of becoming a long-lived plasma cell Hit paper breakdown → | 2006 | 836 |
| 7 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) Hit paper breakdown → | 2019 | 817 |
| 8 | Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis Hit paper breakdown → | 2012 | 798 |
| 9 | EULAR recommendations for the management of systemic lupus erythematosus: 2023 update Hit paper breakdown → | 2023 | 612 |
| 10 | Treat-to-target in systemic lupus erythematosus: recommendations from an international task force Hit paper breakdown → | 2014 | 603 |
| 11 | 2000 | 534 | |
| 12 | Guidelines for the use of flow cytometry and cell sorting in immunological studies * Hit paper breakdown → | 2017 | 469 |
| 13 | Immunopathogenic mechanisms of systemic autoimmune disease Hit paper breakdown → | 2013 | 461 |
| 14 | EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies Hit paper breakdown → | 2019 | 455 |
| 15 | Novel paradigms in systemic lupus erythematosus Hit paper breakdown → | 2019 | 440 |
| 16 | 2011 | 435 | |
| 17 | Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial Hit paper breakdown → | 2018 | 415 |
| 18 | Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis Hit paper breakdown → | 2011 | 372 |
| 19 | 2004 | 366 | |
| 20 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) Hit paper breakdown → | 2021 | 354 |
About Thomas Dörner
Thomas Dörner is a scholar working on Rheumatology, Immunology, Physiology, Hematology and Infectious Diseases, having authored 436 papers that have together received 34.4k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (172 papers), T-cell and B-cell Immunology (80 papers), Rheumatoid Arthritis Research and Therapies (66 papers), Salivary Gland Disorders and Functions (60 papers), Biosimilars and Bioanalytical Methods (12 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Rheumatology (14.8k citations), Immunology (6.7k citations), Physiology (3.5k citations), Pathology and Forensic Medicine (1.7k citations) and Infectious Diseases (1.7k citations). Thomas Dörner has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Peter E. Lipsky, Gerd Rüdiger Burmester, Andreas Radbruch, Eva Vanessa Schrezenmeier, Falk Hiepe, Annett M. Jacobi, Eugen Feist, Richard Alan Furie, Henrik E. Mei and Marie Wahren‐Herlenius. Their work appears in journals such as Annals of the Rheumatic Diseases, Arthritis Research & Therapy, Current Opinion in Rheumatology, Nature Reviews Rheumatology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.